Bausch + Lomb Corporation

15.86+0.6200+4.07%Vol 353.42K1Y Perf -
Jul 1st, 2022 16:00 DELAYED
BID15.00 ASK15.99
Open15.05 Previous Close15.24
Pre-Market- After-Market15.86
 - -  - -%
Target Price
23.43 
Analyst Rating
Moderate Buy 1.73
Potential %
47.73 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     45.78
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     46.04
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
38.26 
Earnings Rating
Market Cap5.55B 
Earnings Date
-
Alpha Standard Deviation
Beta 

Today's Price Range

15.0016.03

52W Range

13.1720.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
0.06%
1 Month
-2.64%
3 Months
-
6 Months
-
1 Year
-
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BLCO15.860.62004.07
AAPL138.932.21001.62
GOOG2 181.62-5.8300-0.27
MSFT259.582.75001.07
XOM87.551.91002.23
WFC39.920.75001.91
JNJ179.522.01001.13
FB196.640.99000.51
GE63.54-0.1300-0.20
JPM114.051.44001.28
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.06-
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume353.42K
Shares Outstanding350.00K
Shares Float35.00M
Trades Count3.52K
Dollar Volume5.57M
Avg. Volume1.05M
Avg. Weekly Volume614.78K
Avg. Monthly Volume966.95K
Avg. Quarterly Volume1.57M

Bausch + Lomb Corporation (NYSE: BLCO) stock closed at 15.86 per share at the end of the most recent trading day (a 4.07% change compared to the prior day closing price) with a volume of 353.42K shares and market capitalization of 5.55B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 19600 people. Bausch + Lomb Corporation CEO is .

The one-year performance of Bausch + Lomb Corporation stock is %, while year-to-date (YTD) performance is %. BLCO stock has a five-year performance of %. Its 52-week range is between 13.1701 and 20.2, which gives BLCO stock a 52-week price range ratio of 38.26%

Bausch + Lomb Corporation currently has a PE ratio of 32.80, a price-to-book (PB) ratio of 0.78, a price-to-sale (PS) ratio of 1.49, a price to cashflow ratio of 8.10, a PEG ratio of 2.32, a ROA of 1.60%, a ROC of 1.86% and a ROE of 2.45%. The company’s profit margin is 4.90%, its EBITDA margin is 19.00%, and its revenue ttm is $3.70 Billion , which makes it $10.57 revenue per share.

Of the last four earnings reports from Bausch + Lomb Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Bausch + Lomb Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Bausch + Lomb Corporation is Moderate Buy (1.73), with a target price of $23.43, which is +47.73% compared to the current price. The earnings rating for Bausch + Lomb Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bausch + Lomb Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bausch + Lomb Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.32, ATR14 : 0.71, CCI20 : 50.82, Chaikin Money Flow : 0.13, MACD : -0.16, Money Flow Index : 64.28, ROC : 15.85, RSI : 47.98, STOCH (14,3) : 82.51, STOCH RSI : 1.00, UO : 55.25, Williams %R : -17.49), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bausch + Lomb Corporation in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (63.64 %)
1 (100.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
4 (36.36 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
Summary RatingModerate Buy
1.73
Strong Buy
1.00
-
0.00

Bausch + Lomb Corporation

Bausch & Lomb Corp is a global eye health company dedicated towards protecting and enhancing the gift of sight for millions of people around the world. It holds portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.

CEO:

Telephone: +1 905 695-7700

Address: 520 Applewood Crescent, Vaughan L4K 4B4, ON, CA

Number of employees: 19 600

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

50%50%

TipRanks News for BLCO

Thu, 09 Jun 2022 16:37 GMT Bausch + Lomb Corporation (BLCO) Gets a Hold Rating from Morgan Stanley

- TipRanks. All rights reserved.

News

Stocktwits